Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	glucuronosyltransferase activity	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	4.15e-07	35	167	6	GO:0015020
GeneOntologyMolecularFunction	monoatomic ion channel activity	ANO4 LRRC8E TPTE2 STING1 CLCN3 NALCN KCNH2 CNGB3 SCN5A SCN9A TRPV2 SCNN1D SLC17A7 ANO7 CNGA4 SLC17A6	1.63e-06	459	167	16	GO:0005216
GeneOntologyMolecularFunction	channel activity	ANO4 LRRC8E TPTE2 STING1 AQP3 CLCN3 NALCN KCNH2 CNGB3 SCN5A SCN9A TRPV2 SCNN1D SLC17A7 ANO7 CNGA4 SLC17A6	2.06e-06	525	167	17	GO:0015267
GeneOntologyMolecularFunction	passive transmembrane transporter activity	ANO4 LRRC8E TPTE2 STING1 AQP3 CLCN3 NALCN KCNH2 CNGB3 SCN5A SCN9A TRPV2 SCNN1D SLC17A7 ANO7 CNGA4 SLC17A6	2.12e-06	526	167	17	GO:0022803
GeneOntologyMolecularFunction	retinoic acid binding	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	3.24e-06	28	167	5	GO:0001972
GeneOntologyMolecularFunction	retinoid binding	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	4.93e-05	48	167	5	GO:0005501
GeneOntologyMolecularFunction	isoprenoid binding	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	5.46e-05	49	167	5	GO:0019840
GeneOntologyMolecularFunction	monoatomic ion transmembrane transporter activity	ANO4 LRRC8E TPTE2 SLC46A1 STING1 SLC6A3 CLCN3 NALCN KCNH2 CNGB3 SCN5A SCN9A TRPV2 SCNN1D SLC17A7 ANO7 CNGA4 SLC17A6	1.20e-04	793	167	18	GO:0015075
GeneOntologyMolecularFunction	transmembrane transporter activity	ANO4 LRRC8E TPTE2 SLC46A1 STING1 AQP3 SLC6A3 CLCN3 NALCN SLC22A16 KCNH2 SLC16A14 CNGB3 SCN5A SCN9A TRPV2 SCNN1D SLC17A7 ANO7 SLC37A2 ABCC12 CNGA4 SLC17A6	1.33e-04	1180	167	23	GO:0022857
GeneOntologyMolecularFunction	transporter activity	ANO4 LRRC8E TPTE2 SLC46A1 STING1 AQP3 SLC6A3 CLCN3 NALCN SLC22A16 KCNH2 SLC16A14 CNGB3 SCN5A SCN9A TRPV2 SCNN1D SLC17A7 ANO7 SLC37A2 ABCC12 RFT1 CNGA4 SLC17A6	1.87e-04	1289	167	24	GO:0005215
GeneOntologyMolecularFunction	L-glutamate uniporter activity	SLC17A7 SLC17A6	2.07e-04	3	167	2	GO:0140788
GeneOntologyMolecularFunction	inorganic molecular entity transmembrane transporter activity	ANO4 SLC46A1 STING1 AQP3 SLC6A3 CLCN3 NALCN KCNH2 SCN5A SCN9A TRPV2 SCNN1D SLC17A7 ANO7 SLC37A2 CNGA4 SLC17A6	2.15e-04	758	167	17	GO:0015318
GeneOntologyMolecularFunction	monoatomic anion channel activity	ANO4 LRRC8E CLCN3 SLC17A7 ANO7 SLC17A6	2.29e-04	103	167	6	GO:0005253
GeneOntologyMolecularFunction	monocarboxylic acid binding	CYP4F8 UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.82e-04	107	167	6	GO:0033293
GeneOntologyMolecularFunction	monoatomic anion transmembrane transporter activity	ANO4 LRRC8E SLC6A3 CLCN3 SLC17A7 ANO7 SLC17A6	2.84e-04	151	167	7	GO:0008509
GeneOntologyMolecularFunction	superoxide-generating NADPH oxidase activity	NOX4 NOX3	4.13e-04	4	167	2	GO:0106292
GeneOntologyMolecularFunction	aliphatic amine oxidase activity	AOC2 AOC3	4.13e-04	4	167	2	GO:0052595
GeneOntologyMolecularFunction	inorganic anion transmembrane transporter activity	ANO4 SLC6A3 CLCN3 SLC17A7 ANO7 SLC37A2 SLC17A6	6.00e-04	171	167	7	GO:0015103
GeneOntologyMolecularFunction	sodium ion transmembrane transporter activity	SLC6A3 NALCN SCN5A SCN9A SCNN1D SLC17A7 SLC17A6	6.00e-04	171	167	7	GO:0015081
GeneOntologyMolecularFunction	chloride transmembrane transporter activity	ANO4 SLC6A3 CLCN3 SLC17A7 ANO7 SLC17A6	6.46e-04	125	167	6	GO:0015108
GeneOntologyMolecularFunction	membrane potential driven uniporter activity	SLC17A7 SLC17A6	6.84e-04	5	167	2	GO:0022810
GeneOntologyMolecularFunction	neurotransmitter transmembrane transporter activity	SLC6A3 SLC17A7 SLC17A6	6.84e-04	21	167	3	GO:0005326
GeneOntologyMolecularFunction	chloride channel activity	ANO4 CLCN3 SLC17A7 ANO7 SLC17A6	7.77e-04	86	167	5	GO:0005254
GeneOntologyMolecularFunction	sodium channel activity	NALCN SCN5A SCN9A SCNN1D	9.35e-04	52	167	4	GO:0005272
GeneOntologyMolecularFunction	phosphate transmembrane transporter activity	SLC17A7 SLC37A2 SLC17A6	1.02e-03	24	167	3	GO:0005315
GeneOntologyMolecularFunction	ligand-gated monoatomic ion channel activity	ANO4 KCNH2 CNGB3 SCNN1D SLC17A7 ANO7 CNGA4	1.22e-03	193	167	7	GO:0015276
GeneOntologyMolecularFunction	voltage-gated sodium channel activity	NALCN SCN5A SCN9A	1.30e-03	26	167	3	GO:0005248
GeneOntologyMolecularFunction	alkali metal ion binding	CAPN3 ADPRH SCN9A	1.30e-03	26	167	3	GO:0031420
GeneOntologyMolecularFunction	hydrolase activity, acting on glycosyl bonds	LYZL6 SI ADPRH GANAB GUSB FUCA1	1.35e-03	144	167	6	GO:0016798
GeneOntologyMolecularFunction	ligand-gated channel activity	ANO4 KCNH2 CNGB3 SCNN1D SLC17A7 ANO7 CNGA4	1.37e-03	197	167	7	GO:0022834
GeneOntologyMolecularFunction	intracellularly cGMP-activated cation channel activity	CNGB3 CNGA4	1.42e-03	7	167	2	GO:0005223
GeneOntologyMolecularFunction	alpha-glucosidase activity	SI GANAB	1.42e-03	7	167	2	GO:0090599
GeneOntologyMolecularFunction	hydrolase activity, hydrolyzing O-glycosyl compounds	LYZL6 SI GANAB GUSB FUCA1	1.74e-03	103	167	5	GO:0004553
GeneOntologyMolecularFunction	UDP-glycosyltransferase activity	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	1.84e-03	153	167	6	GO:0008194
GeneOntologyMolecularFunction	volume-sensitive anion channel activity	LRRC8E CLCN3	2.41e-03	9	167	2	GO:0005225
GeneOntologyMolecularFunction	primary methylamine oxidase activity	AOC2 AOC3	2.41e-03	9	167	2	GO:0008131
GeneOntologyMolecularFunction	monoatomic cation channel activity	STING1 NALCN KCNH2 CNGB3 SCN5A SCN9A TRPV2 SCNN1D CNGA4	2.45e-03	343	167	9	GO:0005261
GeneOntologyMolecularFunction	intracellularly cAMP-activated cation channel activity	CNGB3 CNGA4	2.99e-03	10	167	2	GO:0005222
GeneOntologyMolecularFunction	uniporter activity	SLC17A7 SLC17A6	2.99e-03	10	167	2	GO:0015292
GeneOntologyMolecularFunction	actin filament binding	MYH6 MYH7 MYH13 ADD1 CYFIP1 ANTXR1 PLEC	3.05e-03	227	167	7	GO:0051015
GeneOntologyBiologicalProcess	cellular glucuronidation	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	1.46e-08	21	171	6	GO:0052695
GeneOntologyBiologicalProcess	glucuronate metabolic process	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	5.97e-08	26	171	6	GO:0019585
GeneOntologyBiologicalProcess	uronic acid metabolic process	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	5.97e-08	26	171	6	GO:0006063
GeneOntologyBiologicalProcess	vitamin D3 metabolic process	ENPP1 UGT1A4 UGT1A3	4.53e-05	9	171	3	GO:0070640
GeneOntologyBiologicalProcess	biphenyl metabolic process	CYP4B1 UGT1A1 UGT2B10	6.44e-05	10	171	3	GO:0018879
GeneOntologyBiologicalProcess	bilirubin conjugation	UGT1A4 UGT1A1	6.83e-05	2	171	2	GO:0006789
GeneOntologyCellularComponent	monoatomic ion channel complex	LRRC8E NALCN KCNH2 CNGB3 LRRTM4 SCN5A SCN9A SCNN1D SLC17A7 CATSPERB OLFM2 CNGA4 SLC17A6	1.57e-05	378	172	13	GO:0034702
GeneOntologyCellularComponent	muscle myosin complex	MYH6 MYH7 MYH13	2.83e-04	16	172	3	GO:0005859
GeneOntologyCellularComponent	cell surface	XCR1 IL13RA2 ANPEP BTNL8 ENPP1 LYZL6 TRGV5 SHH SLC46A1 IL17RC ZZEF1 SLC6A3 PROM1 FCRL3 CLCN3 KCNH2 FZD5 SCN5A AOC3 TRPV2 ANTXR1	3.27e-04	1111	172	21	GO:0009986
GeneOntologyCellularComponent	transmembrane transporter complex	LRRC8E NALCN KCNH2 CNGB3 LRRTM4 SCN5A SCN9A SCNN1D SLC17A7 CATSPERB OLFM2 CNGA4 SLC17A6	4.06e-04	523	172	13	GO:1902495
Domain	UDPGT	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	2.03e-08	21	164	6	PF00201
Domain	UDPGT	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	2.03e-08	21	164	6	PS00375
Domain	UDP_glucos_trans	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	2.03e-08	21	164	6	IPR002213
Domain	Ion_trans_dom	TPTE2 NALCN KCNH2 CNGB3 SCN5A SCN9A TRPV2 CNGA4	7.45e-06	114	164	8	IPR005821
Domain	Ion_trans	TPTE2 NALCN KCNH2 CNGB3 SCN5A SCN9A TRPV2 CNGA4	7.45e-06	114	164	8	PF00520
Domain	TPR-contain_dom	TTC24 NAA15 TTC27 IFIT3 CRNKL1 CDC27 KDM6A ZMYND12	5.45e-05	150	164	8	IPR013026
Domain	S10_plectin	RPS10 PLEC	7.66e-05	2	164	2	PF03501
Domain	S10_plectin_N	RPS10 PLEC	7.66e-05	2	164	2	IPR005326
Domain	OLF	OLFML2B OLFML2A OLFM2	1.78e-04	13	164	3	PF02191
Domain	OLF	OLFML2B OLFML2A OLFM2	1.78e-04	13	164	3	PS51132
Domain	Olfac-like_dom	OLFML2B OLFML2A OLFM2	1.78e-04	13	164	3	IPR003112
Domain	OLF	OLFML2B OLFML2A OLFM2	1.78e-04	13	164	3	SM00284
Domain	TPR-like_helical_dom	SART3 TTC24 NAA15 TTC27 IFIT3 CRNKL1 CDC27 KDM6A ZMYND12	2.23e-04	233	164	9	IPR011990
Domain	Rhs_assc_core	TENM2 TENM4	2.29e-04	3	164	2	IPR022385
Domain	-	AOC2 AOC3	2.29e-04	3	164	2	2.70.98.20
Domain	Cu_amine_oxidase_N3	AOC2 AOC3	2.29e-04	3	164	2	IPR015802
Domain	Cu_amine_oxidase_N2	AOC2 AOC3	2.29e-04	3	164	2	IPR015800
Domain	COPPER_AMINE_OXID_1	AOC2 AOC3	2.29e-04	3	164	2	PS01164
Domain	COPPER_AMINE_OXID_2	AOC2 AOC3	2.29e-04	3	164	2	PS01165
Domain	Cu_amine_oxidN2	AOC2 AOC3	2.29e-04	3	164	2	PF02727
Domain	Cu_amine_oxidN3	AOC2 AOC3	2.29e-04	3	164	2	PF02728
Domain	Cu_amine_oxidase_N-reg	AOC2 AOC3	2.29e-04	3	164	2	IPR016182
Domain	Cu_amine_oxid	AOC2 AOC3	2.29e-04	3	164	2	PF01179
Domain	Cu_amine_oxidase_C	AOC2 AOC3	2.29e-04	3	164	2	IPR015798
Domain	Myosin_N	MYH6 MYH7 MYH13	2.80e-04	15	164	3	PF02736
Domain	Myosin_N	MYH6 MYH7 MYH13	2.80e-04	15	164	3	IPR004009
Domain	MFS	SLC46A1 SLC22A16 SLC16A14 SLC17A7 SLC37A2 SLC17A6	3.82e-04	108	164	6	PS50850
Domain	Gal_mutarotase_SF_dom	SI GANAB LGI3	4.13e-04	17	164	3	IPR011013
Domain	Tox-GHH_dom	TENM2 TENM4	4.55e-04	4	164	2	IPR028916
Domain	Cyt_b245_heavy_chain	NOX4 NOX3	4.55e-04	4	164	2	IPR000778
Domain	Glyco_hydro_31_CS	SI GANAB	4.55e-04	4	164	2	IPR030459
Domain	Tox-GHH	TENM2 TENM4	4.55e-04	4	164	2	PF15636
Domain	Ten_N	TENM2 TENM4	4.55e-04	4	164	2	IPR009471
Domain	Ten_N	TENM2 TENM4	4.55e-04	4	164	2	PF06484
Domain	TENEURIN_N	TENM2 TENM4	4.55e-04	4	164	2	PS51361
Domain	Cu_amine_oxidase	AOC2 AOC3	4.55e-04	4	164	2	IPR000269
Domain	Myosin_tail_1	MYH6 MYH7 MYH13	4.92e-04	18	164	3	PF01576
Domain	Myosin_tail	MYH6 MYH7 MYH13	4.92e-04	18	164	3	IPR002928
Domain	Myosin-like_IQ_dom	MYH6 MYH7 MYH13	5.81e-04	19	164	3	IPR027401
Domain	-	MYH6 MYH7 MYH13	5.81e-04	19	164	3	4.10.270.10
Domain	MFS_1	SLC46A1 SLC16A14 SLC17A7 SLC37A2 SLC17A6	5.83e-04	77	164	5	PF07690
Domain	MFS	SLC46A1 SLC16A14 SLC17A7 SLC37A2 SLC17A6	5.83e-04	77	164	5	IPR011701
Domain	TPR_REGION	TTC24 NAA15 TTC27 IFIT3 CDC27 KDM6A ZMYND12	6.45e-04	165	164	7	PS50293
Domain	TPR	TTC24 NAA15 TTC27 IFIT3 CDC27 KDM6A ZMYND12	6.45e-04	165	164	7	PS50005
Domain	6-blade_b-propeller_TolB-like	LRP1B TENM2 TENM4 LGI3	7.02e-04	46	164	4	IPR011042
Domain	IQ	MYH6 MYH7 MYH13 SCN5A SCN9A	7.35e-04	81	164	5	SM00015
Domain	GLYCOSYL_HYDROL_F31_2	SI GANAB	7.53e-04	5	164	2	PS00707
Domain	YD	TENM2 TENM4	7.53e-04	5	164	2	IPR006530
Domain	-	GGCX KCNH2 CNGB3 CNGA4	8.25e-04	48	164	4	2.60.120.10
Domain	TPR	TTC24 NAA15 TTC27 IFIT3 CDC27 KDM6A	9.78e-04	129	164	6	SM00028
Domain	RmlC-like_jellyroll	GGCX KCNH2 CNGB3 CNGA4	1.04e-03	51	164	4	IPR014710
Domain	Na_trans_cytopl	SCN5A SCN9A	1.12e-03	6	164	2	PF11933
Domain	Glyco_hydro_31_AS	SI GANAB	1.12e-03	6	164	2	IPR030458
Domain	Na_trans_cytopl	SCN5A SCN9A	1.12e-03	6	164	2	IPR024583
Domain	TPR_repeat	TTC24 NAA15 TTC27 IFIT3 CDC27 KDM6A	1.15e-03	133	164	6	IPR019734
Domain	TPR_1	TTC24 NAA15 IFIT3 CDC27 KDM6A	1.18e-03	90	164	5	IPR001440
Domain	TPR_1	TTC24 NAA15 IFIT3 CDC27 KDM6A	1.18e-03	90	164	5	PF00515
Domain	IQ_motif_EF-hand-BS	MYH6 MYH7 MYH13 SCN5A SCN9A	1.18e-03	90	164	5	IPR000048
Domain	MFS_dom	SLC46A1 SLC22A16 SLC16A14 SLC17A7 SLC37A2 SLC17A6	1.19e-03	134	164	6	IPR020846
Domain	Glycoside_hydrolase_SF	SI GANAB GUSB FUCA1	1.20e-03	53	164	4	IPR017853
Domain	TPR_8	NAA15 IFIT3 CDC27 KDM6A	1.20e-03	53	164	4	PF13181
Domain	IQ	MYH6 MYH7 MYH13 SCN5A SCN9A	1.37e-03	93	164	5	PS50096
Domain	Anoct_dimer	ANO4 ANO7	1.56e-03	7	164	2	PF16178
Domain	Glyco_hydro_31	SI GANAB	1.56e-03	7	164	2	IPR000322
Domain	Anoct_dimer	ANO4 ANO7	1.56e-03	7	164	2	IPR032394
Domain	Glyco_hydro_31	SI GANAB	1.56e-03	7	164	2	PF01055
Domain	NAD_binding_6	NOX4 NOX3	1.56e-03	7	164	2	PF08030
Domain	FAD_binding_8	NOX4 NOX3	1.56e-03	7	164	2	PF08022
Domain	GLYCOSYL_HYDROL_F31_1	SI GANAB	1.56e-03	7	164	2	PS00129
Domain	FAD-bd_8	NOX4 NOX3	1.56e-03	7	164	2	IPR013112
Domain	Fe_red_NAD-bd_6	NOX4 NOX3	1.56e-03	7	164	2	IPR013121
Domain	Channel_four-helix_dom	TPTE2 NALCN SCN5A SCN9A	1.58e-03	57	164	4	IPR027359
Domain	-	TPTE2 NALCN SCN5A SCN9A	1.58e-03	57	164	4	1.20.120.350
Domain	Somatomedin_B	ENPP1 SUSD2	2.07e-03	8	164	2	PF01033
Domain	-	TTC24 NAA15 TTC27 IFIT3 CRNKL1 KDM6A ZMYND12	2.39e-03	207	164	7	1.25.40.10
Domain	SO	ENPP1 SUSD2	2.65e-03	9	164	2	SM00201
Domain	CNMP_BINDING_1	KCNH2 CNGB3 CNGA4	2.73e-03	32	164	3	PS00888
Domain	CNMP_BINDING_2	KCNH2 CNGB3 CNGA4	2.73e-03	32	164	3	PS00889
Domain	cNMP	KCNH2 CNGB3 CNGA4	3.26e-03	34	164	3	SM00100
Domain	cNMP_binding	KCNH2 CNGB3 CNGA4	3.26e-03	34	164	3	PF00027
Domain	Somatomedin_B_dom	ENPP1 SUSD2	3.29e-03	10	164	2	IPR001212
Domain	Na_channel_asu	SCN5A SCN9A	3.29e-03	10	164	2	IPR001696
Domain	SMB_1	ENPP1 SUSD2	3.29e-03	10	164	2	PS00524
Domain	Na_trans_assoc	SCN5A SCN9A	3.29e-03	10	164	2	IPR010526
Domain	Anoctamin	ANO4 ANO7	3.29e-03	10	164	2	PF04547
Domain	Anoctamin	ANO4 ANO7	3.29e-03	10	164	2	IPR007632
Domain	HAT	SART3 CRNKL1	3.29e-03	10	164	2	SM00386
Domain	Na_trans_assoc	SCN5A SCN9A	3.29e-03	10	164	2	PF06512
Domain	SMB_2	ENPP1 SUSD2	3.29e-03	10	164	2	PS50958
Domain	HAT	SART3 CRNKL1	3.29e-03	10	164	2	IPR003107
Domain	TPR_7	TTC24 IFIT3	3.29e-03	10	164	2	PF13176
Domain	cNMP-bd_dom	KCNH2 CNGB3 CNGA4	3.54e-03	35	164	3	IPR000595
Domain	CNMP_BINDING_3	KCNH2 CNGB3 CNGA4	3.54e-03	35	164	3	PS50042
Domain	Myosin_head_motor_dom	MYH6 MYH7 MYH13	4.48e-03	38	164	3	IPR001609
Domain	cNMP-bd-like	KCNH2 CNGB3 CNGA4	4.48e-03	38	164	3	IPR018490
Domain	MYOSIN_MOTOR	MYH6 MYH7 MYH13	4.48e-03	38	164	3	PS51456
Domain	Myosin_head	MYH6 MYH7 MYH13	4.48e-03	38	164	3	PF00063
Domain	MYSc	MYH6 MYH7 MYH13	4.48e-03	38	164	3	SM00242
Domain	Ferric_reduct	NOX4 NOX3	4.77e-03	12	164	2	PF01794
Domain	Fe3_Rdtase_TM_dom	NOX4 NOX3	4.77e-03	12	164	2	IPR013130
Pathway	KEGG_STARCH_AND_SUCROSE_METABOLISM	ENPP1 UGT1A6 UGT1A5 SI UGT1A4 UGT1A1 UGT1A3 GUSB UGT2B10	8.96e-10	52	129	9	M14171
Pathway	KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB UGT2B10	4.60e-09	28	129	7	M19580
Pathway	KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB UGT2B10	7.92e-08	41	129	7	M7399
Pathway	REACTOME_GLUCURONIDATION	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	8.02e-08	25	129	6	M17787
Pathway	KEGG_ASCORBATE_AND_ALDARATE_METABOLISM	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	8.02e-08	25	129	6	M605
Pathway	WP_GLUCURONIDATION	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	1.04e-07	26	129	6	M39404
Pathway	KEGG_DRUG_METABOLISM_OTHER_ENZYMES	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB UGT2B10	3.78e-07	51	129	7	M17726
Pathway	REACTOME_GLUCURONIDATION	UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	2.19e-06	24	129	5	MM14599
Pathway	WP_GLUCURONIDATION	UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	2.72e-06	25	129	5	MM15820
Pathway	REACTOME_ASPIRIN_ADME	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	2.77e-06	44	129	6	M45014
Pathway	KEGG_STEROID_HORMONE_BIOSYNTHESIS	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	1.05e-05	55	129	6	M14933
Pathway	KEGG_RETINOL_METABOLISM	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	2.54e-05	64	129	6	M9488
Pathway	REACTOME_HEME_DEGRADATION	UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.89e-05	20	129	4	MM14721
Pathway	REACTOME_BIOLOGICAL_OXIDATIONS	CYP4F8 CYP4B1 UGT1A5 AOC2 UGT1A4 UGT1A1 UGT1A3 GGTLC1 AOC3 UGT2B10	3.28e-05	219	129	10	MM14838
Pathway	REACTOME_BIOLOGICAL_OXIDATIONS	CYP4F8 CYP4B1 UGT1A6 UGT1A5 AOC2 UGT1A4 UGT1A1 UGT1A3 AOC3 UGT2B10	3.41e-05	220	129	10	M10320
Pathway	KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	4.24e-05	70	129	6	M16794
Pathway	WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II	CYP4F8 CYP4B1 UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 CHST12 HS3ST4	4.63e-05	183	129	9	M39588
Pathway	KEGG_DRUG_METABOLISM_CYTOCHROME_P450	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	4.98e-05	72	129	6	M9257
Pathway	REACTOME_PREDNISONE_ADME	UGT1A5 UGT1A4 UGT1A3 UGT2B10	5.18e-05	23	129	4	MM16639
Pathway	REACTOME_ASPIRIN_ADME	UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	5.41e-05	45	129	5	MM15694
Pathway	REACTOME_METABOLISM_OF_PORPHYRINS	UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.97e-04	32	129	4	MM14719
Pathway	REACTOME_ATORVASTATIN_ADME	UGT1A5 UGT1A4 UGT1A3	3.14e-04	15	129	3	MM15697
Pathway	REACTOME_STIMULI_SENSING_CHANNELS	ANO4 CLCN3 NALCN TRPV2 SCNN1D ANO7	4.22e-04	106	129	6	M27200
Pathway	REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS	UGT1A5 UGT1A4 UGT1A1 UGT1A3 GGTLC1 UGT2B10	4.44e-04	107	129	6	MM14595
Pathway	REACTOME_DRUG_ADME	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	4.90e-04	109	129	6	M45012
Pathway	REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	4.90e-04	109	129	6	M18788
Pathway	WP_METAPATHWAY_BIOTRANSFORMATION	CYP4B1 UGT1A5 UGT1A4 UGT1A1 UGT1A3 CHST12 HS3ST4	5.12e-04	153	129	7	MM15844
Pathway	WP_ESTROGEN_METABOLISM_WP697	UGT1A6 UGT1A1 UGT1A3	5.52e-04	18	129	3	M39424
Pathway	REACTOME_DRUG_ADME	UGT1A5 UGT1A4 UGT1A1 UGT1A3 GGTLC1 UGT2B10	7.80e-04	119	129	6	MM15692
Pathway	WP_ESTROGEN_METABOLISM	UGT1A5 UGT1A1 UGT1A3	1.02e-03	22	129	3	MM15888
Pubmed	Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation.	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 PLEC	3.89e-11	14	172	6	14672974
Pubmed	A genome-wide association study identifies UGT1A1 as a regulator of serum cell-free DNA in young adults: The Cardiovascular Risk in Young Finns Study.	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	3.46e-10	9	172	5	22511988
Pubmed	A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini.	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	3.46e-10	9	172	5	1339448
Pubmed	Association of SNPs in the UGT1A gene cluster with total bilirubin and mortality in the Diabetes Heart Study.	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	6.89e-10	10	172	5	23642732
Pubmed	UDP-glucuronosyltransferases.	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	6.89e-10	10	172	5	11465080
Pubmed	A genome-wide association study for serum bilirubin levels and gene-environment interaction in a Chinese population.	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	6.89e-10	10	172	5	23371916
Pubmed	A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia.	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	6.89e-10	10	172	5	22558097
Pubmed	Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia.	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.15e-09	12	172	5	19419973
Pubmed	Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus.	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.15e-09	12	172	5	11434514
Pubmed	UGT1A1 is a major locus influencing bilirubin levels in African Americans.	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	3.48e-09	13	172	5	22085899
Pubmed	Genome-wide analysis of hepatic lipid content in extreme obesity.	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	3.48e-09	13	172	5	25246029
Pubmed	Mayo Genome Consortia: a genotype-phenotype resource for genome-wide association studies with an application to the analysis of circulating bilirubin levels.	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	5.39e-09	14	172	5	21646302
Pubmed	Human UDP-glucuronosyltransferases: metabolism, expression, and disease.	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	5.39e-09	14	172	5	10836148
Pubmed	The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence.	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	5.39e-09	14	172	5	9295054
Pubmed	Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population.	UGT1A6 UGT1A4 UGT1A1 UGT1A3	8.60e-09	6	172	4	19204906
Pubmed	Genome-wide association meta-analysis for total serum bilirubin levels.	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.17e-08	16	172	5	19414484
Pubmed	Genome-wide association of serum bilirubin levels in Korean population.	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.65e-08	17	172	5	20639394
Pubmed	A genome-wide assessment of variability in human serum metabolism.	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	3.07e-08	19	172	5	23281178
Pubmed	Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro.	UGT1A6 UGT1A4 UGT1A1 UGT1A3	3.98e-08	8	172	4	20610558
Pubmed	Simultaneous evaluation of six human glucuronidation activities in liver microsomes using liquid chromatography-tandem mass spectrometry.	UGT1A6 UGT1A4 UGT1A1 UGT1A3	3.98e-08	8	172	4	22579593
Pubmed	Oligomerization of the UDP-glucuronosyltransferase 1A proteins: homo- and heterodimerization analysis by fluorescence resonance energy transfer and co-immunoprecipitation.	UGT1A6 UGT1A4 UGT1A1 UGT1A3	3.98e-08	8	172	4	17179145
Pubmed	Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism.	UGT1A4 UGT1A1 UGT1A3 GUSB	3.98e-08	8	172	4	12695355
Pubmed	Genetic determinants influencing human serum metabolome among African Americans.	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.10e-07	24	172	5	24625756
Pubmed	Vesicular glutamate transporters use flexible anion and cation binding sites for efficient accumulation of neurotransmitter.	CLCN3 SLC17A7 SLC17A6	1.19e-07	3	172	3	25433636
Pubmed	Isolation and characterization of a UDP-glucuronosyltransferase (UGT1A01) cloned from female rhesus monkey.	UGT1A5 UGT1A1 UGT1A3	1.19e-07	3	172	3	12051676
Pubmed	Human UDP-glucuronosyltransferase (UGT) 2B10 in drug N-glucuronidation: substrate screening and comparison with UGT1A3 and UGT1A4.	UGT1A4 UGT1A3 UGT2B10	1.19e-07	3	172	3	23611809
Pubmed	Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans.	UGT1A6 UGT1A4 UGT1A1 UGT1A3	2.77e-07	12	172	4	20308471
Pubmed	Detoxification enzyme polymorphisms are not involved in duodenal adenomatosis in familial adenomatous polyposis.	UGT1A6 UGT1A4 UGT1A1 UGT1A3	2.77e-07	12	172	4	18161889
Pubmed	Genetic variations and haplotypes of UDP-glucuronosyltransferase 1A locus in a Korean population.	UGT1A5 UGT1A4 UGT1A1	4.74e-07	4	172	3	18223459
Pubmed	Cloning of two human liver bilirubin UDP-glucuronosyltransferase cDNAs with expression in COS-1 cells.	UGT1A6 UGT1A4 UGT1A1	4.74e-07	4	172	3	1898728
Pubmed	Urinary excretion of phenytoin metabolites, 5-(4'-hydroxyphenyl)-5-phenylhydantoin and its O-glucuronide in humans and analysis of genetic polymorphisms of UDP-glucuronosyltransferases.	UGT1A6 UGT1A4 UGT1A1	4.74e-07	4	172	3	15855726
Pubmed	Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8.	UGT1A4 UGT1A1 UGT1A3	4.74e-07	4	172	3	9535849
Pubmed	Identification of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler-Najjar syndrome type II.	UGT1A6 UGT1A4 UGT1A1	4.74e-07	4	172	3	8280139
Pubmed	Mechanisms of inherited deficiencies of multiple UDP-glucuronosyltransferase isoforms in two patients with Crigler-Najjar syndrome, type I.	UGT1A6 UGT1A4 UGT1A1	4.74e-07	4	172	3	1634050
Pubmed	Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2.	UGT1A6 UGT1A4 UGT1A1	4.74e-07	4	172	3	8276413
Pubmed	Functional suppression of Kcnq1 leads to early sodium channel remodelling and cardiac conduction system dysmorphogenesis.	MYH6 MYH7 KCNH2 SCN5A	5.56e-07	14	172	4	23542581
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	CCDC134 DHX36 ANPEP ENPP1 ERMP1 ZZEF1 CTSA LRP1B GGCX OLFML2A FOXRED2 GANAB CELSR2 GUSB TRAM1 TMEM245 PIN1 IPO13 ANTXR1 CHST12 RFT1	5.79e-07	1201	172	21	35696571
Pubmed	Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy.	CYP4B1 UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	9.53e-07	66	172	6	19898482
Pubmed	A photoswitchable GPCR-based opsin for presynaptic inhibition.	SLC6A3 SLC17A7 SLC17A6	1.18e-06	5	172	3	33979635
Pubmed	Isolation of cDNAs for mouse phenol and bilirubin UDP-glucuronosyltransferases and mapping of the mouse gene for phenol UDP-glucuronosyltransferase (Ugtla1) to chromosome 1 by restriction fragment length variations.	UGT1A5 UGT1A1 UGT1A3	1.18e-06	5	172	3	7677729
Pubmed	Conditional Single Vector CRISPR/SaCas9 Viruses for Efficient Mutagenesis in the Adult Mouse Nervous System.	SLC6A3 SLC17A7 SLC17A6	2.35e-06	6	172	3	32209486
Pubmed	Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37.	UGT1A5 UGT1A4 UGT1A1	4.10e-06	7	172	3	8467709
Pubmed	Molecular cloning of two cDNAs encoding the mouse bilirubin/phenol family of UDP-glucuronosyltransferases (mUGTBr/p).	UGT1A5 UGT1A1 UGT1A3	4.10e-06	7	172	3	8464825
Pubmed	PRISM: A Progenitor-Restricted Intersectional Fate Mapping Approach Redefines Forebrain Lineages.	SHH SLC17A7 SLC17A6	6.54e-06	8	172	3	32574593
Pubmed	Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine.	UGT1A1 UGT1A3 UGT2B10	6.54e-06	8	172	3	10748067
Pubmed	Human metabolic individuality in biomedical and pharmaceutical research.	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	9.49e-06	57	172	5	21886157
Pubmed	Human immunodeficiency virus type 1 gp120 induces apoptosis in human primary neurons through redox-regulated activation of neutral sphingomyelinase.	NOX4 NOX3 SMPD2	9.77e-06	9	172	3	15509740
Pubmed	Discovery and refinement of loci associated with lipid levels.	UGT1A6 UGT1A5 CAPN3 UGT1A4 UGT1A1 UGT1A3 CELSR2 PLEC	1.11e-05	211	172	8	24097068
Pubmed	Utility of frozen cell lines in medium throughput electrophysiology screening of hERG and NaV1.5 blockade.	KCNH2 SCN5A	2.43e-05	2	172	2	21996251
Pubmed	ENPP1 is an innate immune checkpoint of the anticancer cGAMP-STING pathway in breast cancer.	ENPP1 STING1	2.43e-05	2	172	2	38117852
Pubmed	Reversible epigenetic modifications of the two cardiac myosin heavy chain genes during changes in expression.	MYH6 MYH7	2.43e-05	2	172	2	21526716
Pubmed	Cloning and characterization of cDNAs encoding mouse Ugt1.6 and rabbit UGT1.6: differential induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin.	UGT1A5 UGT1A3	2.43e-05	2	172	2	8068691
Pubmed	Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites.	SLC17A7 SLC17A6	2.43e-05	2	172	2	15118123
Pubmed	Genetic deletion of vesicular glutamate transporter in dopamine neurons increases vulnerability to MPTP-induced neurotoxicity in mice.	SLC6A3 SLC17A6	2.43e-05	2	172	2	30442663
Pubmed	The AQP-3 water channel is a pivotal modulator of glycerol-induced chloride channel activation in nasopharyngeal carcinoma cells.	AQP3 CLCN3	2.43e-05	2	172	2	26794461
Pubmed	Disrupting Glutamate Co-transmission Does Not Affect Acquisition of Conditioned Behavior Reinforced by Dopamine Neuron Activation.	SLC6A3 SLC17A6	2.43e-05	2	172	2	28297663
Pubmed	Characterization of human cardiac myosin heavy chain genes.	MYH6 MYH7	2.43e-05	2	172	2	2726733
Pubmed	Human UGT1A4 and UGT1A3 conjugate 25-hydroxyvitamin D3: metabolite structure, kinetics, inducibility, and interindividual variability.	UGT1A4 UGT1A3	2.43e-05	2	172	2	24641623
Pubmed	Transiently increased colocalization of vesicular glutamate transporters 1 and 2 at single axon terminals during postnatal development of mouse neocortex: a quantitative analysis with correlation coefficient.	SLC17A7 SLC17A6	2.43e-05	2	172	2	18028110
Pubmed	Association of Arrhythmia-Related Genetic Variants With Phenotypes Documented in Electronic Medical Records.	KCNH2 SCN5A	2.43e-05	2	172	2	26746457
Pubmed	Mutation in NADPH oxidase 3 (NOX3) impairs SHH signaling and increases cerebellar neural stem/progenitor cell proliferation.	SHH NOX3	2.43e-05	2	172	2	30853403
Pubmed	D1 receptor-expressing neurons in ventral tegmental area alleviate mouse anxiety-like behaviors via glutamatergic projection to lateral septum.	SLC6A3 SLC17A6	2.43e-05	2	172	2	36195641
Pubmed	Gastrointestinal symptoms in families of patients with an SCN5A-encoded cardiac channelopathy: evidence of an intestinal channelopathy.	KCNH2 SCN5A	2.43e-05	2	172	2	16771953
Pubmed	Human cardiac myosin heavy chain genes and their linkage in the genome.	MYH6 MYH7	2.43e-05	2	172	2	3037493
Pubmed	β-myosin heavy chain is induced by pressure overload in a minor subpopulation of smaller mouse cardiac myocytes.	MYH6 MYH7	2.43e-05	2	172	2	21778428
Pubmed	Structural organization of the human cardiac alpha-myosin heavy chain gene (MYH6).	MYH6 MYH7	2.43e-05	2	172	2	8307559
Pubmed	Non tumoral hyperserotoninaemia responsive to octreotide due to dual polymorphism in UGT1A1 and UGT1A6.	UGT1A6 UGT1A1	2.43e-05	2	172	2	22450351
Pubmed	Glutamate corelease promotes growth and survival of midbrain dopamine neurons.	SLC6A3 SLC17A6	2.43e-05	2	172	2	23197738
Pubmed	Molecular cloning and characterization of human cardiac alpha- and beta-form myosin heavy chain complementary DNA clones. Regulation of expression during development and pressure overload in human atrium.	MYH6 MYH7	2.43e-05	2	172	2	2969919
Pubmed	Expression of vesicular glutamate transporters type 1 and 2 in sensory and autonomic neurons innervating the mouse colorectum.	SLC17A7 SLC17A6	2.43e-05	2	172	2	21800314
Pubmed	Combined UGT1A1 and UGT1A6 genotypes together with a stressful life event increase breast cancer risk.	UGT1A6 UGT1A1	2.43e-05	2	172	2	20686835
Pubmed	Distribution and structure-function relationship of myosin heavy chain isoforms in the adult mouse heart.	MYH6 MYH7	2.43e-05	2	172	2	17575272
Pubmed	Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the alpha cardiac myosin heavy chain gene.	MYH6 MYH7	2.43e-05	2	172	2	9884344
Pubmed	Role of microtubules versus myosin heavy chain isoforms in contractile dysfunction of hypertrophied murine cardiocytes.	MYH6 MYH7	2.43e-05	2	172	2	12750067
Pubmed	Transgenic mouse α- and β-cardiac myosins containing the R403Q mutation show isoform-dependent transient kinetic differences.	MYH6 MYH7	2.43e-05	2	172	2	23580644
Pubmed	Altered vesicular glutamate transporter expression in the anterior cingulate cortex in schizophrenia.	SLC17A7 SLC17A6	2.43e-05	2	172	2	18155679
Pubmed	Coexistence of Andersen-Tawil Syndrome with Polymorphisms in hERG1 Gene (K897T) and SCN5A Gene (H558R) in One Family.	KCNH2 SCN5A	2.43e-05	2	172	2	26109178
Pubmed	Enhanced sucrose and cocaine self-administration and cue-induced drug seeking after loss of VGLUT2 in midbrain dopamine neurons in mice.	SLC6A3 SLC17A6	2.43e-05	2	172	2	21880920
Pubmed	Characterizing the effects of common UDP glucuronosyltransferase (UGT) 1A6 and UGT1A1 polymorphisms on cis- and trans-resveratrol glucuronidation.	UGT1A6 UGT1A1	2.43e-05	2	172	2	19406951
Pubmed	Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics.	KCNH2 SCN5A	2.43e-05	2	172	2	23277474
Pubmed	Activation of parabrachial nucleus - ventral tegmental area pathway underlies the comorbid depression in chronic neuropathic pain in mice.	SLC6A3 SLC17A6	2.43e-05	2	172	2	34731609
Pubmed	Expression of the vesicular glutamate transporters-1 and -2 in adult mouse dorsal root ganglia and spinal cord and their regulation by nerve injury.	SLC17A7 SLC17A6	2.43e-05	2	172	2	17577523
Pubmed	β-Myosin heavy chain variant Val606Met causes very mild hypertrophic cardiomyopathy in mice, but exacerbates HCM phenotypes in mice carrying other HCM mutations.	MYH6 MYH7	2.43e-05	2	172	2	24829265
Pubmed	Dopamine neurons projecting to the posterior striatum reinforce avoidance of threatening stimuli.	SLC6A3 SLC17A6	2.43e-05	2	172	2	30177795
Pubmed	Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart.	MYH6 MYH7	2.43e-05	2	172	2	2036722
Pubmed	Ensemble force changes that result from human cardiac myosin mutations and a small-molecule effector.	MYH6 MYH7	2.43e-05	2	172	2	25937279
Pubmed	Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia.	SLC17A7 SLC17A6	2.43e-05	2	172	2	19839996
Pubmed	Digenic heterozygous mutations of KCNH2 and SCN5A induced young and early-onset long QT syndrome and sinoatrial node dysfunction.	KCNH2 SCN5A	2.43e-05	2	172	2	34755423
Pubmed	Cardiac channelopathies associated with infantile fatal ventricular arrhythmias: from the cradle to the bench.	KCNH2 SCN5A	2.43e-05	2	172	2	24112685
Pubmed	Myocardial contraction is 5-fold more economical in ventricular than in atrial human tissue.	MYH6 MYH7	2.43e-05	2	172	2	15621050
Pubmed	Haploinsufficiency of VGluT1 but not VGluT2 impairs extinction of spatial preference and response suppression.	SLC17A7 SLC17A6	2.43e-05	2	172	2	23396167
Pubmed	Vesicular glutamate transporter VGLUT1 has a role in hippocampal long-term potentiation and spatial reversal learning.	SLC17A7 SLC17A6	2.43e-05	2	172	2	19574394
Pubmed	Molecular cloning of a novel brain-type Na(+)-dependent inorganic phosphate cotransporter.	SLC17A7 SLC17A6	2.43e-05	2	172	2	10820226
Pubmed	Disruption of VGLUT1 in Cholinergic Medial Habenula Projections Increases Nicotine Self-Administration.	SLC17A7 SLC17A6	2.43e-05	2	172	2	34876472
Pubmed	Coordinating brain-distributed network activities in memory resistant to extinction.	SLC6A3 SLC17A6	2.43e-05	2	172	2	38242086
Pubmed	Functional effects of the hypertrophic cardiomyopathy R403Q mutation are different in an alpha- or beta-myosin heavy chain backbone.	MYH6 MYH7	2.43e-05	2	172	2	18480046
Pubmed	Interplay between VGLUT isoforms and endophilin A1 regulates neurotransmitter release and short-term plasticity.	SLC17A7 SLC17A6	2.43e-05	2	172	2	21435559
Pubmed	Olfactomedin domain-containing proteins: possible mechanisms of action and functions in normal development and pathology.	OLFML2B OLFM2	2.43e-05	2	172	2	19554483
Pubmed	Vesicular glutamate transporters VGLUT1 and VGLUT2 in the developing mouse barrel cortex.	SLC17A7 SLC17A6	2.43e-05	2	172	2	17289331
Pubmed	Murine pulmonary myocardium: developmental analysis of cardiac gene expression.	MYH6 MYH7	2.43e-05	2	172	2	7919499
Cytoband	2q37	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.09e-07	31	172	5	2q37
Cytoband	Ensembl 112 genes in cytogenetic band chr2q37	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 OTOS ANO7	2.51e-05	226	172	7	chr2q37
GeneFamily	UDP glucuronosyltransferases	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	5.10e-08	32	117	6	363
GeneFamily	Myosin heavy chains	MYH6 MYH7 MYH13	1.14e-04	15	117	3	1098
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	TTC24 TTC27 IFIT3 CDC27 KDM6A	9.07e-04	115	117	5	769
GeneFamily	Sodium voltage-gated channel alpha subunits	SCN5A SCN9A	1.45e-03	9	117	2	1203
GeneFamily	Cyclic nucleotide gated channels	CNGB3 CNGA4	1.81e-03	10	117	2	250
GeneFamily	Anoctamins	ANO4 ANO7	1.81e-03	10	117	2	865
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OXGR1 LYZL6 LRP1B SLC6A3 FREM2 CNGB3 SCN9A SLC17A6	9.88e-08	145	172	8	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CAPN3 TTC27 ERMP1 STING1 BCL11B SACS TRPV2 HERC3	2.67e-07	165	172	8	0c80abf13409767825ef8a507b498afafa7e89c5
ToppCell	E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CAPN3 TTC27 ERMP1 STING1 BCL11B SACS TRPV2 HERC3	2.67e-07	165	172	8	cced77f2d74b07010307d7f4788b8cf3fdaeb91a
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 PROM1 TENM4 NALCN KCNH2 LRRTM4 ANTXR1 GPR176	6.37e-07	185	172	8	6712512100ccef456d2e2bd201d0987986c92ac9
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 PROM1 TENM4 NALCN KCNH2 LRRTM4 ANTXR1 GPR176	6.37e-07	185	172	8	3b2dfc8f4c87be516265dbecfc251276034d0efd
ToppCell	Parenchymal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANO4 OLFML2B PAPLN TENM2 TENM4 CNGB3 GPNMB GPR176	1.10e-06	199	172	8	6f5ef959b51eccf1ffc2e5ddf0d83c62ca2257b2
ToppCell	Parenchymal-NucSeq-Stromal-Peri/Epineurial_\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANO4 OLFML2B PAPLN TENM2 TENM4 CNGB3 GPNMB GPR176	1.10e-06	199	172	8	1aa99d21bf61b86df4a966dc47634044430aa39f
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	SELENBP1 CYP4B1 AQP3 FZD5 SUSD2 TMEM245 LGI3 RNF145	1.14e-06	200	172	8	acc771a902cf2f060c3eb9aedb72a256f5778a6c
ToppCell	Parenchyma_COVID-19-Epithelial-TX-AT2-2\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	SELENBP1 CYP4B1 AQP3 FZD5 SUSD2 TMEM245 LGI3 RNF145	1.14e-06	200	172	8	ceb613ac6cdf0e3e6bb3f04d89034e18a524cefb
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SELENBP1 CYP4B1 AQP3 FZD5 SUSD2 TMEM245 LGI3 RNF145	1.14e-06	200	172	8	eb44d1f80ecaac3a022cd04ab16dc36151e45488
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 PROM1 TENM4 NALCN LRRTM4 ANTXR1 GPR176	7.29e-06	183	172	7	12daaea821e49bc94a01e2496331e92a80d27339
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MYH13 OGFR RGS22 LRP1B TENM4 PLEC AGTPBP1	8.10e-06	186	172	7	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	COVID-19-kidney-TAL\|COVID-19 / Disease (COVID-19 only), tissue and cell type	OXR1 LRP1B PROM1 TENM4 BBOX1 FHIP1A WDR72	9.63e-06	191	172	7	fe55475ce0666ab5122447a813dc2369e24947b8
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 RGS22 PROM1 TENM4 NALCN NAV2 GPR176	9.63e-06	191	172	7	b133ee1c0e58d00ddd2e4e05b01fd04947524c18
ToppCell	COVID_vent-Lymphocytic-T_cell-CD4+_T_cell_(ISG_high)\|COVID_vent / Disease condition, Lineage, Cell class and subclass	MYH6 CYP4B1 ENPP1 UGT1A4 SLC35F3 CNGB3	9.64e-06	126	172	6	a1ea8cf6b444a640544d204dfaf5ff219dc31aa9
ToppCell	5'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Enterocyte\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ANPEP BTNL8 SI CTSA AQP3 TMEM45B SOAT2	1.07e-05	194	172	7	fcbf9c4f3801ab1a34fcd62c752fabc97fc7bde1
ToppCell	COVID-19-kidney-TAL\|kidney / Disease (COVID-19 only), tissue and cell type	OXR1 LRP1B PROM1 TENM4 TMEM45B NAV2 FHIP1A	1.14e-05	196	172	7	04f5eb206ed3016a737609a3ebac0c1fcabb94ef
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SHH FREM2 TENM4 TMEM45B CATSPERB BBOX1 WDR72	1.14e-05	196	172	7	b07db4a53ab9be9aad6fae5e45f9547db829d096
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANO4 FREM2 SLC35F3 KCNH2 SCN9A SLC17A7 WDR72	1.14e-05	196	172	7	ef650ff106a76c1e926e13c7f002fbc452cc48ae
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANO4 IL13RA2 FREM2 SLC35F3 KCNH2 SCN9A WDR72	1.14e-05	196	172	7	72b6a68ee760599ea86cd2d712bfd17b7b4ee417
ToppCell	Bronchus_Control_(B.)-Epithelial-TX-Basal_1\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	ANO4 OXGR1 AQP3 SLC35F3 KCNH2 SCN9A WDR72	1.22e-05	198	172	7	f632342e1e8911dd82b5df171776a84c7dc3f931
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_macrophage\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	OLFML2B SLC46A1 FOXRED2 CYFIP1 STON2 FUCA1 GPNMB	1.22e-05	198	172	7	9aaff68107ae4542f904b142d23669f2fcd557ac
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	OLFML2B SLC46A1 FOXRED2 CYFIP1 STON2 FUCA1 GPNMB	1.22e-05	198	172	7	5aaf3861c53763cf09bb628c9d2eabb6a7277021
ToppCell	Caecum-(1)_T_cell-(16)_Tfh\|Caecum / shred on region, Cell_type, and subtype	SELENBP1 STING1 SLFN5 BCL11B TMEM45B TRBV7-6 PLEC	1.26e-05	199	172	7	d07d77ae426dd1164d80d7031f14befa0369d3e5
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal-Intermediate\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	LRRC8E ERMP1 RSPH1 FZD5 FUCA1 BBOX1 SOAT2	1.26e-05	199	172	7	cf592d93612023a13de21e0fb8c6b13714f9af71
ToppCell	Caecum-T_cell-Tfh\|Caecum / Region, Cell class and subclass	SELENBP1 STING1 SLFN5 BCL11B TMEM45B TRBV7-6 PLEC	1.26e-05	199	172	7	fb40f37d842f170ed101dfa3bffdb8f3b2c94f19
ToppCell	5'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ANPEP BTNL8 CAPN3 SI CTSA TMEM45B SOAT2	1.30e-05	200	172	7	73bfdf068a8ecbefc1e6afe9686df73658ee042f
ToppCell	5'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ANPEP BTNL8 CAPN3 SI CTSA TMEM45B SOAT2	1.30e-05	200	172	7	3e13c9a4ba99a7dfbf738b0fb63fb54b4dee5897
ToppCell	Parenchymal-10x3prime_v2-Epithelial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SELENBP1 CYP4B1 AQP3 RSPH1 SUSD2 GGTLC1 RNF145	1.30e-05	200	172	7	16828c6a2be66bbbd805453325d6da719f2dea1b
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	ANO4 OLFML2B ARHGEF25 PROM1 NALCN KCNH2 CLEC11A	1.30e-05	200	172	7	02cae2c296a13ad4cbb53bca7a86d64629d67d66
ToppCell	facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLC6A3 OTOS TMEM45B SCN9A SLC17A7 FHIP1A	2.06e-05	144	172	6	e9d62f202f0fa8747961036ef0eafed91fe8a42f
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Akr1c18_Ntf3\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	IMPA2 IFIT3 KCNH2 SCN9A GPNMB GPR176	2.50e-05	149	172	6	1e77f03d2b32f366018fec3462d1b75f6e7febb9
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-24m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPS10 SHH AQP3 TENM2 TMEM45B BBOX1	2.50e-05	149	172	6	d259e9137109eeb2662022f0915ca463f5bebdfe
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	DUSP18 MYH7 CAPN3 LRRTM4 PREX1 SLC17A6	3.86e-05	161	172	6	e3327c296d48e821004e61a573abb75624a6f040
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gad2_(generic_SN/VTA_GABAergic_neuron)--\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	MYH13 CNGB3 OR2D3 WDR72	4.14e-05	50	172	4	d902816790b9499793708fca2c7d2fa8025cfd2a
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gad2_(generic_SN/VTA_GABAergic_neuron)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	MYH13 CNGB3 OR2D3 WDR72	4.14e-05	50	172	4	8903d7bd7c2fd2f4c06af7166ab210871a482b13
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gad2_(generic_SN/VTA_GABAergic_neuron)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	MYH13 CNGB3 OR2D3 WDR72	4.14e-05	50	172	4	318112bc843e6bcb6636fa8bdb05270f5fb4eda2
ToppCell	facs-Skin-nan-24m-Epithelial-bulge_keratinocyte\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTC24 RPS10 LYZL6 AQP3 TENM2 ANGPTL7	4.28e-05	164	172	6	7a65c7a6dbe5fb9067f83efafbb7ec8206d79325
ToppCell	severe_influenza-pDC\|World / disease group, cell group and cell class (v2)	TTC24 FOXRED2 SLC35F3 RSPH1 SCN9A FHIP1A	5.23e-05	170	172	6	b9c08af83241666bbdbed9109cadcd088c0f647d
ToppCell	390C-Lymphocytic-ILC\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	TTC24 ENPP1 CTSA NAV2 FUCA1 GPR176	5.40e-05	171	172	6	70963f79711fe6088d6d01b29206b17ab89e5e73
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-ependymal_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RGS22 RSPH1 BBOX1 CNGA4 FBXO15 ZMYND12	5.76e-05	173	172	6	a7cc63bb3ab41feb9e4072700d44dbbbc62c47c6
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-Ependyma\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RGS22 RSPH1 BBOX1 CNGA4 FBXO15 ZMYND12	5.76e-05	173	172	6	e3e3a67a5a93ef4475224a256d45ae24526383cc
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Endothelial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPP40 CECR2 TENM2 FREM2 CASKIN2 LGI3	5.95e-05	174	172	6	c58328c2f262506a4518f49f148e29874faf9171
ToppCell	severe_influenza-pDC\|severe_influenza / disease group, cell group and cell class (v2)	TTC24 FOXRED2 SLC35F3 RSPH1 SCN9A FHIP1A	5.95e-05	174	172	6	d8d2ded5812ed3b3db4109585714a6513c13326a
ToppCell	10x3'2.3-week_17-19-Lymphocytic_T-T_NK-Treg\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TRGV5 NBEA SLFN5 AQP3 ADPRH BCL11B	5.95e-05	174	172	6	7ca39c9ecd609e5ade30dac1a948a4a4fff1b3b2
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	AOC2 PAPLN FREM2 CLEC11A SUSD2 TACR2	5.95e-05	174	172	6	4da79da7a09ee1e345102c5331675ebcdbe56171
ToppCell	COVID-mDC1\|COVID / Condition, Cell_class and T cell subcluster	XCR1 ANPEP ENPP1 CAPN3 IGLV1-40 SCN9A	6.14e-05	175	172	6	b9280444016e21c28131a61df65cc5c56d402412
ToppCell	COVID-mDC1-\|COVID / Condition, Cell_class and T cell subcluster	XCR1 ANPEP ENPP1 CAPN3 IGLV1-40 SCN9A	6.14e-05	175	172	6	83a95d6fc2ddf3ec53f05825bbc982fb8d2ccd15
ToppCell	10x3'2.3-week_14-16-Lymphocytic_T-T_NK-Treg\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MYH7 SLFN5 AQP3 BCL11B FCRL3 OLFM2	6.33e-05	176	172	6	2eb1827171e9c19f945e87824215721f8cf22258
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CYP4B1 CECR2 SHH SUSD2 NAV2 FHIP1A	6.54e-05	177	172	6	9af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	OXR1 PAPLN PROM1 TENM4 GPR176 WDR72	6.74e-05	178	172	6	544379f5a6145429762258d426b876bb36c112f5
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	OXR1 TENM4 SLC35F3 NAV2 PLEC HS3ST4	6.74e-05	178	172	6	a0ab20c588e7d43d0320d4779d9ab95c1c86e297
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 PROM1 TENM4 NALCN LRRTM4 ANTXR1	6.95e-05	179	172	6	02c90d8306016365ed811f0c63cfb3ac7b85464c
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ENPP1 NOX4 PAPLN CLEC11A ANTXR1 GPR176	7.17e-05	180	172	6	935c091bbcd6d10b81dc4731779e5bd98205c99f
ToppCell	5'-Airway_Nasal-Mesenchymal\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ENPP1 NOX4 PAPLN CLEC11A ANTXR1 GPR176	7.17e-05	180	172	6	3dd384b7f3d9582b8fec9fe05100e466e6218b76
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CYP4B1 CECR2 SHH SUSD2 NAV2 FHIP1A	7.39e-05	181	172	6	b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OLFML2A RSPH1 SUSD2 AOC3 TRPV2 BBOX1	7.39e-05	181	172	6	c1b1e62440805800a3a600b1ddd79be1c9762598
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-AT1-AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IMPA2 SELENBP1 CYP4B1 SHH SUSD2 FHIP1A	7.62e-05	182	172	6	cc79e0cc21e2fdc4ef77f052818d27b9f707aec1
ToppCell	PCW_05-06-Neuronal-Neuronal_SCP\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	OLFML2A LRRTM4 SCN9A HS3ST4 ANGPTL7 PREX1	7.62e-05	182	172	6	b4fc5e4f5d8440a3c9ee0a6fd0da87b43cabc8c6
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 PROM1 TENM4 NALCN LRRTM4 GPR176	7.86e-05	183	172	6	7eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ENPP1 NOX4 PAPLN CLEC11A ANTXR1 GPR176	7.86e-05	183	172	6	803376f5260de83c48d4f7301278d078a32b3e6e
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ENPP1 NOX4 PAPLN CLEC11A ANTXR1 GPR176	7.86e-05	183	172	6	6d98973098c6d20c5305bce6a83a549a7d8dbfba
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ENPP1 NOX4 PAPLN CLEC11A ANTXR1 GPR176	7.86e-05	183	172	6	cc7f5a17b40e8d901885174922e5fa8877643071
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CYP4B1 CECR2 SHH SUSD2 NAV2 FHIP1A	7.86e-05	183	172	6	ff6dde877659cde9daa3263db0932c9c9ef1adac
ToppCell	Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Pdgfa_(Mural.Rgs5Acta2.Pdgfa)-\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	ANPEP AOC2 OLFML2A AOC3 FHIP1A	8.08e-05	114	172	5	2cc5d2da5573650c5232a01e2d2128082c4bffcb
ToppCell	Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Pdgfa_(Mural.Rgs5Acta2.Pdgfa)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	ANPEP AOC2 OLFML2A AOC3 FHIP1A	8.08e-05	114	172	5	fceb7cc590a47380145fc0d854c9f2350dbb0a59
ToppCell	facs-Skin-nan-18m-Epithelial-epidermal_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UGT1A1 KCNH2 SUSD2 NAV2 OLFM2 BBOX1	8.10e-05	184	172	6	dc7f6ee4062856a02423fff8b1cce62d46a9355c
ToppCell	PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CYP4B1 SHH FREM2 SLC35F3 STON2 FHIP1A	8.10e-05	184	172	6	fa4915b0498f3069fd5ef497286445528f75187e
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPP40 RGS22 FREM2 RSPH1 SLC37A2 FHIP1A	8.34e-05	185	172	6	05bc89a566b0db90ae06506e067190a4739a0974
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	RPS10 SLFN5 AQP3 IFIT3 BCL11B LRRTM4	8.34e-05	185	172	6	406b52516b26e9fe2c9e768950af447ec7ad5f3e
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	RPS10 SLFN5 AQP3 IFIT3 BCL11B LRRTM4	8.34e-05	185	172	6	f2ebd099c8dfcfaca4298bcdd618c50701a9c2c8
ToppCell	(2)_Fibroblasts-(20)_Fibro-1\|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis	ANPEP OLFML2B OLFML2A AOC3 ANTXR1 GPNMB	8.59e-05	186	172	6	e93415b59dd89bc8a966dab0e0b65fe215933598
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CYP4B1 CECR2 SHH SUSD2 NAV2 FHIP1A	8.59e-05	186	172	6	3aebe163799109ffc67e4e10ee47c2dd0886a92c
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SLFN5 BCL11B PPP2R5E GVINP1 PCNX1 AGTPBP1	8.85e-05	187	172	6	e61c1755531469dd3850c9740474b5ad4e0499c1
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	ANO4 TENM2 TENM4 NALCN LRRTM4 ANTXR1	8.85e-05	187	172	6	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	COVID-19-Epithelial_cells-Airway_basal\|COVID-19 / group, cell type (main and fine annotations)	CYP4B1 UGT1A6 AQP3 UGT1A1 UGT1A3 FHIP1A	8.85e-05	187	172	6	8407a82e98f56a94ea26562bcb6bbe00a8f41661
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 RGS22 ARHGEF25 PROM1 NALCN ANTXR1	9.11e-05	188	172	6	3177b2c1723268d330d3e9f24f9e24492ace6286
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 RGS22 PROM1 TENM4 NALCN GPR176	9.38e-05	189	172	6	45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.4\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RGS22 NBEA PROM1 SLC35F3 RSPH1 SCN9A	9.38e-05	189	172	6	cd4746ea6ae48a7dd14a2960d38d9445a738cf2c
ToppCell	3'-Adult-LargeIntestine-Mesenchymal-myocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ARHGEF25 KCNH2 AOC3 ANTXR1 TACR2 GPR176	9.38e-05	189	172	6	f7e2ee5047792ab9ef6472fa88e2d193cdea6fa0
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SELENBP1 CECR2 CAPN3 PAPLN STON2 PREX1	9.38e-05	189	172	6	37ecbd73408d462b47d7e5611f203143e08a2689
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	OXR1 ERMP1 LRP1B PROM1 TENM4 NAV2	9.66e-05	190	172	6	bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	OXR1 CECR2 LRP1B BCL11B TENM4 FHIP1A	9.66e-05	190	172	6	cc17ab84a9328124f146951c06be3eff9650d9fd
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	OXR1 ERMP1 LRP1B PROM1 TENM4 NAV2	9.66e-05	190	172	6	b6b8964b4910083499681b5fdf554e127b6a4c4e
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 OLFML2B ARHGEF25 TENM2 NALCN ANTXR1	9.94e-05	191	172	6	08042952431ca1a6fd7dfc13f36eb28643979598
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANPEP ARHGEF25 OLFML2A SUSD2 AOC3 TRPV2	9.94e-05	191	172	6	cb75e6c36dbe2e091e407d691c063ec7c4fd5f90
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANPEP ARHGEF25 OLFML2A SUSD2 AOC3 TRPV2	9.94e-05	191	172	6	b2cffea7860dd590b505ee0ebd51aa1978cb5e64
ToppCell	severe-Lymphocytic-CD4_T_cells_3\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	STING1 AQP3 ADPRH BCL11B FCRL3 NALCN	9.94e-05	191	172	6	afff6bfae9a2f1e17d2731315e7fe63c4601679f
ToppCell	PCW_05-06-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	SHH TENM2 FREM2 TMEM45B SCN9A FHIP1A	9.94e-05	191	172	6	05731ece7867659c662f952812805f947032fe10
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	UGT1A6 RPS10 SLFN5 AQP3 BCL11B LRRTM4	9.94e-05	191	172	6	c5e22df4a8741b8096cdd1618271fd48d6265846
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	CYP4B1 FREM2 CELSR2 TMEM245 NAV2 FHIP1A	9.94e-05	191	172	6	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	COVID-19-kidney-Mito-rich_Distal\|COVID-19 / Disease (COVID-19 only), tissue and cell type	OXR1 LRP1B PROM1 TENM4 BBOX1 WDR72	9.94e-05	191	172	6	0965f621ebcd92ccdeb21cc27022180ce3cfe910
ToppCell	Control-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	SELENBP1 FREM2 SUSD2 LGI3 CATSPERB FHIP1A	1.02e-04	192	172	6	1bfd022d5b87cf8a5d5069f559339a553a52a0a2
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CYP4B1 FREM2 CELSR2 TMEM245 NAV2 FHIP1A	1.02e-04	192	172	6	29f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCell	COPD-Epithelial\|COPD / Disease state, Lineage and Cell class	SELENBP1 CYP4B1 RSPH1 SUSD2 NAV2 FHIP1A	1.02e-04	192	172	6	0644fad5df18f0021f6f49cca996d8cf47f972ff
ToppCell	severe-Myeloid-Neutrophils_3\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	ANPEP IDS JAK1 TMEM45B PCNX1 PREX1	1.05e-04	193	172	6	f4d43dfbf4115dd0f843ea5cf08049220342a047
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	OLFML2B FREM2 KCNH2 AOC3 NAV2 TACR2	1.05e-04	193	172	6	173f1d83133f5ffa88e2a75d28835ad7acd2aa90
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	STING1 AQP3 IFIT3 AOC3 TRPV2 GPNMB	1.05e-04	193	172	6	aa679fb27f914a931e51cff7153861cde0edfd85
ToppCell	VE-mDC1-\|VE / Condition, Cell_class and T cell subcluster	XCR1 IMPA2 ANPEP ENPP1 FZD5 FUCA1	1.05e-04	193	172	6	5df6033bc0e4f96a20d526486a8e89c990e21831
ToppCell	VE-mDC1\|VE / Condition, Cell_class and T cell subcluster	XCR1 IMPA2 ANPEP ENPP1 FZD5 FUCA1	1.05e-04	193	172	6	12b2708db9db8b88365b8ebeb4908f28c50081bb
Drug	NNAL	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB UGT2B10 PLEC	6.11e-11	32	166	8	CID000104856
Drug	N-OH-DABZ	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB	1.22e-10	12	166	6	CID000051366
Drug	3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB UGT2B10 PLEC	1.34e-10	35	166	8	CID010436171
Drug	estradiol-3-glucuronide	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB UGT2B10	2.14e-10	23	166	7	CID000066651
Drug	cotinine-N-glucuronide	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	2.26e-10	13	166	6	CID000000411
Drug	naphthyl sulphate	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB	6.50e-10	15	166	6	CID000114775
Drug	benzphetamine	CYP4F8 CYP4B1 UGT1A6 UGT1A5 UGT1A4 UGT1A1 SLC6A3 UGT1A3 AOC3 UGT2B10 PLEC	1.19e-09	119	166	11	CID000002341
Drug	7-hydroxycoumarin glucuronide	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB UGT2B10	1.32e-09	29	166	7	CID000125641
Drug	ethyl-beta-D-6-glucosiduronic acid	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB	2.37e-09	18	166	6	CID000152226
Drug	C1 11-32	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	2.37e-09	18	166	6	CID000443077
Drug	C11131	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	2.37e-09	18	166	6	CID000443076
Drug	AC1MRQNQ	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.39e-09	9	166	5	CID003522271
Drug	DHPASiU	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.39e-09	9	166	5	CID000197602
Drug	3-iodophenol	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.39e-09	9	166	5	CID000012272
Drug	AC1L4J7U	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.39e-09	9	166	5	CID000186631
Drug	Chebi:32663	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.39e-09	9	166	5	CID005460873
Drug	almokalant	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 KCNH2	3.44e-09	19	166	6	CID003033962
Drug	norbuprenorphine	UGT1A6 UGT1A5 IDS UGT1A4 UGT1A1 UGT1A3 GUSB	3.51e-09	33	166	7	CID000114976
Drug	AC1Q6OQG	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB UGT2B10	3.51e-09	33	166	7	CID000009686
Drug	geniposide	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB SMPD2	3.51e-09	33	166	7	CID000107848
Drug	AC1NQGK1	UGT1A6 UGT1A5 CAPN3 UGT1A4 UGT1A1 UGT1A3 GUSB UGT2B10	3.86e-09	52	166	8	CID005195977
Drug	AC1L1OBF	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB	4.89e-09	20	166	6	CID000032736
Drug	AC1NOWCJ	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB UGT2B10	5.46e-09	35	166	7	CID005120112
Drug	estriol-16-glucuronide	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	6.80e-09	21	166	6	CID000122281
Drug	dulcin	OGFR UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	6.80e-09	21	166	6	CID000009013
Drug	4-nitrophenyl)imidazole	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	8.65e-09	11	166	5	CID000123155
Drug	AC1O5XMV	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	8.65e-09	11	166	5	CID006442661
Drug	1-O-beta-D-glucopyranosyl-D-mannitol	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.47e-08	12	166	5	CID000088735
Drug	2,4,6-TCB	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.47e-08	12	166	5	CID000037247
Drug	nonanoyl-N-methylglucamide	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.47e-08	12	166	5	CID000160090
Drug	7,7,7-triphenylheptanoic acid	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.47e-08	12	166	5	CID000276709
Drug	AC1Q7AUJ	CYP4F8 CYP4B1 UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 AOC3 UGT2B10 PLEC	1.47e-08	117	166	10	CID000003303
Drug	buprenorphine hydrochloride solution	OGFR UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	1.76e-08	41	166	7	CID000002476
Drug	testosterone glucuronide	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB UGT2B10	1.76e-08	41	166	7	CID000108192
Drug	N-acetylbenzidine	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB	2.17e-08	25	166	6	CID000018787
Drug	tritanol	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.38e-08	13	166	5	CID000006457
Drug	5-azido-UDP-glucuronic acid	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.38e-08	13	166	5	CID003081279
Drug	2-naphthol	CYP4F8 CYP4B1 UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB UGT2B10	2.67e-08	93	166	9	CID000008663
Drug	beta-naphthoflavone	CYP4F8 ANPEP CYP4B1 UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB AOC3 UGT2B10 PLEC	2.83e-08	200	166	12	CID000002361
Drug	AC1MRGT8	OGFR UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB SCN9A	3.05e-08	67	166	8	CID003517815
Drug	diflunisal	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB	3.58e-08	27	166	6	CID000003059
Drug	propranolol glucuronide	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	3.68e-08	14	166	5	CID000119515
Drug	PCB-61	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	3.68e-08	14	166	5	CID000036401
Drug	N-hydroxy-4-aminobiphenyl	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB	4.53e-08	28	166	6	CID000081261
Drug	2,2',3,5,5'-pentachlorobiphenyl	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	5.49e-08	15	166	5	CID000040469
Drug	afloqualone	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	5.49e-08	15	166	5	CID000002040
Drug	coumarin-3-carboxylic acid	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	5.49e-08	15	166	5	CID000010752
Drug	sulforaphane nitrile	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	5.49e-08	15	166	5	CID000543743
Drug	salicylamide	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB UGT2B10	5.52e-08	48	166	7	CID000005147
Drug	trans-3'-hydroxycotinine	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB	5.67e-08	29	166	6	CID000000414
Drug	iberin	UGT1A6 UGT1A5 SI UGT1A4 UGT1A1 UGT1A3	5.67e-08	29	166	6	CID000010455
Drug	2,2,2-trichloroethanol	CYP4F8 CYP4B1 UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	6.06e-08	73	166	8	CID000008259
Drug	tolcapone	UGT1A6 UGT1A5 UGT1A4 UGT1A1 SLC6A3 UGT1A3	7.05e-08	30	166	6	CID004659569
Drug	AC1L9E0Q	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB	7.05e-08	30	166	6	CID000443095
Drug	quercetin-3,4'-diglucoside	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	7.94e-08	16	166	5	CID005320835
Drug	1'-hydroxyestragole	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	7.94e-08	16	166	5	CID000040003
Drug	bilirubin-phosphate	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	7.94e-08	16	166	5	CID005497144
Drug	amitriptyline	UGT1A6 UGT1A5 CTSA UGT1A4 UGT1A1 SLC6A3 UGT1A3 KCNH2 SCN9A UGT2B10	8.22e-08	140	166	10	CID000002160
Drug	4'-HPPH	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB	8.69e-08	31	166	6	CID000017732
Drug	aniline	CYP4F8 CYP4B1 UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB AOC3 UGT2B10	9.40e-08	142	166	10	CID000006115
Drug	AC1N8H7N	OGFR UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB UGT2B10	1.02e-07	78	166	8	CID004318740
Drug	3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.12e-07	17	166	5	CID000003573
Drug	6-hydroxychrysene	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.12e-07	17	166	5	CID000037766
Drug	2 E1	CYP4F8 CYP4B1 UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB AOC3 UGT2B10	1.14e-07	145	166	10	CID006102788
Drug	R(-)-Denopamine	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 SCN5A	1.29e-07	33	166	6	CID000003818
Drug	BP-3,6-quinol	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	1.29e-07	33	166	6	CID000119292
Drug	SureCN12722713	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.54e-07	18	166	5	CID005488034
Drug	Br 2	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.54e-07	18	166	5	CID003060900
Drug	2,3,7-trichlorodibenzo-p-dioxin	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.54e-07	18	166	5	CID000036614
Drug	ApApG	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.54e-07	18	166	5	CID003081975
Drug	lamotrigine	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 KCNH2 SCN5A SCN9A SCNN1D	1.83e-07	116	166	9	CID000003878
Drug	estrone-3-glucuronide	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	1.87e-07	35	166	6	CID000115255
Drug	9-OH-risperidone	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.08e-07	19	166	5	CID000475100
Drug	5alpha-spirostan-3beta-ol	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.08e-07	19	166	5	CID000091433
Drug	phenolphthalein	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB UGT2B10	2.12e-07	58	166	7	CID000004764
Drug	alpha-naphthoflavone	CYP4F8 CYP4B1 UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 AOC3 UGT2B10	2.12e-07	118	166	9	CID000011790
Drug	7-ethoxycoumarin	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB AOC3 UGT2B10	2.21e-07	86	166	8	CID000035703
Drug	urochloralic acid	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10 QARS1	2.39e-07	59	166	7	CID003036914
Drug	4-hydroxybiphenyl	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB UGT2B10	2.39e-07	59	166	7	CID000007103
Drug	acetaminophen glucuronide	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB UGT2B10	2.39e-07	59	166	7	CID000083944
Drug	SN-38G	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB UGT2B10	2.39e-07	59	166	7	CID000443154
Drug	pentoxyresorufin	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 AOC3 UGT2B10 PLEC	2.42e-07	87	166	8	CID000107683
Drug	acotiamide	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 KCNH2	2.65e-07	37	166	6	CID005282338
Drug	6beta-hydroxytestosterone	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 AOC3	2.65e-07	37	166	6	CID000065543
Drug	N-Fg	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GPR176	2.65e-07	37	166	6	CID000445227
Drug	l-borneol	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	2.65e-07	37	166	6	CID000010049
Drug	tectochrysin	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.75e-07	20	166	5	CID005281954
Drug	4'-hydroxydiclofenac	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.75e-07	20	166	5	CID000116545
Drug	4-methylumbelliferyl glucuronide	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB	3.12e-07	38	166	6	CID000091553
Drug	acacetin	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 KCNH2	3.12e-07	38	166	6	CID005280442
Drug	Benzamidoxime hydrochloride	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	3.59e-07	21	166	5	CID000069186
Drug	4-aminobiphenyl	UGT1A6 UGT1A5 STING1 UGT1A4 UGT1A1 UGT1A3 GUSB UGT2B10	3.73e-07	92	166	8	CID000007102
Drug	2-hydroxyestradiol	SELENBP1 UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 SACS	3.79e-07	63	166	7	CID000009684
Drug	3-OHBaP	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB UGT2B10	3.79e-07	63	166	7	CID000025890
Drug	hexobarbital	CYP4F8 NAA15 CYP4B1 UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	3.98e-07	127	166	9	CID000003608
Drug	harmol	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 UGT2B10	4.29e-07	40	166	6	CID000068094
Drug	AC1L1FK5	UGT1A6 UGT1A5 SHH IDS UGT1A4 UGT1A1 UGT1A3 GUSB UGT2B10	4.54e-07	129	166	9	CID000003272
Drug	amonafide	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	4.62e-07	22	166	5	CID000050515
Drug	N-methylpiperazine	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	4.62e-07	22	166	5	CID000053167
Drug	DCNB	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 GUSB SCN9A UGT2B10	4.78e-07	95	166	8	CID000007443
Disease	X-11442 measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	5.80e-10	9	162	5	EFO_0021236
Disease	X-11441 measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	5.80e-10	9	162	5	EFO_0021235
Disease	circulating cell free DNA measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	5.80e-10	9	162	5	EFO_0004739
Disease	bilirubin measurement, response to xenobiotic stimulus	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	5.80e-10	9	162	5	EFO_0004570, GO_0009410
Disease	bilirubin measurement, response to tenofovir	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.16e-09	10	162	5	EFO_0004570, EFO_0009279
Disease	UDP-glucuronosyltransferase 1-6 measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.16e-09	10	162	5	EFO_0802185
Disease	histidine betaine (hercynine) measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.11e-09	11	162	5	EFO_0800972
Disease	X-21796 measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.11e-09	11	162	5	EFO_0800825
Disease	insomnia, bilirubin measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.11e-09	11	162	5	EFO_0004570, EFO_0004698
Disease	aldosterone measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.11e-09	11	162	5	EFO_0010219
Disease	biliverdin measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	3.60e-09	12	162	5	EFO_0021033
Disease	low density lipoprotein cholesterol measurement, body fat percentage	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.75e-08	17	162	5	EFO_0004611, EFO_0007800
Disease	X-11793--oxidized bilirubin measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A3	6.02e-08	8	162	4	EFO_0021260
Disease	Succinimide measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A3	6.02e-08	8	162	4	EFO_0022118
Disease	X-11530 measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A3	6.02e-08	8	162	4	EFO_0021249
Disease	sulfate of piperine metabolite C16H19NO3 (2) measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A3	6.02e-08	8	162	4	EFO_0801034
Disease	cholelithiasis, bilirubin measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A3	6.02e-08	8	162	4	EFO_0004570, EFO_0004799
Disease	X-11522 measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A3	6.02e-08	8	162	4	EFO_0800696
Disease	X-10458 measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A3	6.02e-08	8	162	4	EFO_0800692
Disease	X-24849 measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A3	6.02e-08	8	162	4	EFO_0800909
Disease	membrane-associated progesterone receptor component 1 measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A3	6.02e-08	8	162	4	EFO_0802740
Disease	X-16946 measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A3	6.02e-08	8	162	4	EFO_0800766
Disease	sulfate of piperine metabolite C18H21NO3 (3) measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A3	1.08e-07	9	162	4	EFO_0801037
Disease	sulfate of piperine metabolite C18H21NO3 (1) measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A3	1.08e-07	9	162	4	EFO_0801036
Disease	X-11880 measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A3	1.08e-07	9	162	4	EFO_0800698
Disease	protein-tyrosine kinase 6 measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A3	1.08e-07	9	162	4	EFO_0020691
Disease	testis-specific chromodomain protein Y 1 measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A3	1.08e-07	9	162	4	EFO_0802127
Disease	X-21448 measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A3	1.79e-07	10	162	4	EFO_0800816
Disease	X-23974 measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A3	1.79e-07	10	162	4	EFO_0800867
Disease	plasma N-desmethylclozapine measurement	UGT1A6 UGT1A5 UGT1A4 UGT2B10	2.80e-07	11	162	4	EFO_0600039
Disease	p-cresol glucuronide measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A3	4.19e-07	12	162	4	EFO_0800079
Disease	xanthurenate measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	5.01e-07	29	162	5	EFO_0010551
Disease	response to dolutegravir	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	5.98e-07	30	162	5	EFO_0600017
Disease	retinol dehydrogenase 16 measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A3	6.02e-07	13	162	4	EFO_0802007
Disease	urate measurement, spine bone mineral density	UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3 NAV2	7.98e-07	58	162	6	EFO_0004531, EFO_0007701
Disease	angiopoietin-related protein 1 measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A3	2.52e-06	18	162	4	EFO_0801382
Disease	tissue factor measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A3	4.87e-06	21	162	4	EFO_0010623
Disease	serum N-desmethylclozapine measurement	UGT1A6 UGT1A5 UGT2B10	8.92e-06	8	162	3	EFO_0600043
Disease	cholelithiasis	UGT1A6 UGT1A5 NSD1 UGT1A4 UGT1A1 UGT1A3	9.33e-06	88	162	6	EFO_0004799
Disease	Limb-girdle muscular dystrophy	MYH6 MYH7 CAPN3 PLEC	1.19e-05	26	162	4	cv:C0686353
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH6 MYH7 MYH13	1.89e-05	10	162	3	DOID:0111269 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH6 MYH7 MYH13	1.89e-05	10	162	3	DOID:0111602 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH6 MYH7 MYH13	1.89e-05	10	162	3	DOID:0111596 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH6 MYH7 MYH13	1.89e-05	10	162	3	DOID:0110454 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH6 MYH7 MYH13	1.89e-05	10	162	3	DOID:0080719 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH6 MYH7 MYH13	1.89e-05	10	162	3	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH6 MYH7 MYH13	1.89e-05	10	162	3	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH6 MYH7 MYH13	1.89e-05	10	162	3	DOID:0080326 (implicated_via_orthology)
Disease	pregnenetriol sulfate measurement	UGT1A6 UGT1A5 UGT1A4	2.60e-05	11	162	3	EFO_0800586
Disease	gallstones	ANPEP UGT1A6 UGT1A5 UGT1A4 UGT1A1 UGT1A3	3.01e-05	108	162	6	EFO_0004210
Disease	distal myopathy (implicated_via_orthology)	MYH6 MYH7 MYH13	3.45e-05	12	162	3	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH6 MYH7 MYH13	3.45e-05	12	162	3	DOID:2106 (implicated_via_orthology)
Disease	electrocardiography	MYH6 OLFML2B PXDC1 SHH PROM1 KCNH2 TMEM245 SCN5A NAV2 PCNX1 GPNMB PLEC	3.92e-05	530	162	12	EFO_0004327
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH6 MYH7 MYH13	4.46e-05	13	162	3	DOID:397 (implicated_via_orthology)
Disease	pregnenetriol disulfate measurement	UGT1A6 UGT1A5 UGT1A4	4.46e-05	13	162	3	EFO_0800587
Disease	T wave morphology measurement	OLFML2B KCNH2 SCN5A	5.66e-05	14	162	3	EFO_0008398
Disease	distal arthrogryposis (implicated_via_orthology)	MYH6 MYH7 MYH13	7.04e-05	15	162	3	DOID:0050646 (implicated_via_orthology)
Disease	Sick sinus syndrome	MYH6 SCN5A	8.95e-05	3	162	2	cv:C0037052
Disease	Torsades de Pointes	KCNH2 SCN5A	8.95e-05	3	162	2	C0040479
Disease	Familial sick sinus syndrome	MYH6 SCN5A	8.95e-05	3	162	2	cv:C0340491
Disease	X-21441 measurement	UGT1A6 UGT1A5 UGT1A4	1.04e-04	17	162	3	EFO_0800814
Disease	Cardiomyopathy, Familial Hypertrophic, 1 (disorder)	MYH6 MYH7	1.78e-04	4	162	2	C3495498
Disease	Hypertrophic cardiomyopathy 1	MYH6 MYH7	1.78e-04	4	162	2	cv:C3495498
Disease	Caveolinopathy	MYH6 MYH7	1.78e-04	4	162	2	cv:C5679790
Disease	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH6 MYH7	1.78e-04	4	162	2	192600
Disease	sick sinus syndrome (is_implicated_in)	MYH6 SCN5A	2.96e-04	5	162	2	DOID:13884 (is_implicated_in)
Disease	STARGARDT DISEASE 1 (disorder)	PROM1 CNGB3	2.96e-04	5	162	2	C1855465
Disease	Sick Sinus Syndrome	MYH6 SCN5A	4.43e-04	6	162	2	C0037052
Disease	Stargardt's disease	PROM1 CNGB3	4.43e-04	6	162	2	C0271093
Disease	Primary familial dilated cardiomyopathy	MYH6 MYH7 SCN5A	5.91e-04	30	162	3	cv:C0340427
Disease	long QT syndrome (is_implicated_in)	KCNH2 SCN5A	6.18e-04	7	162	2	DOID:2843 (is_implicated_in)
Disease	HWESASXX measurement	ANPEP CNGB3	6.18e-04	7	162	2	EFO_0021147
Disease	Idiopathic hypertrophic subaortic stenosis	MYH6 MYH7	6.18e-04	7	162	2	C0700053
Disease	autism spectrum disorder (is_marker_for)	SHH CYFIP1	6.18e-04	7	162	2	DOID:0060041 (is_marker_for)
Disease	Obstructive asymmetric septal hypertrophy	MYH6 MYH7	6.18e-04	7	162	2	C0597124
Disease	temporal lobe epilepsy (biomarker_via_orthology)	SHH ADD1 CYFIP1	6.52e-04	31	162	3	DOID:3328 (biomarker_via_orthology)
Disease	peripheral arterial disease, traffic air pollution measurement	IMPA2 OXR1 SHH NBEA LRRTM4 NAV2	7.32e-04	194	162	6	EFO_0004265, EFO_0007908
Disease	serum metabolite measurement	CYP4B1 UGT1A6 UGT1A5 OXGR1 ERMP1 UGT1A4 UGT1A1 UGT1A3 BCL11B CELSR2 TMEM45B SLC22A16 BBOX1 PHLPP2	7.50e-04	945	162	14	EFO_0005653
Disease	word list delayed recall measurement, memory performance	TENM4 LRRTM4 HS3ST4	7.85e-04	33	162	3	EFO_0004874, EFO_0006805
Disease	plasma clozapine measurement	UGT1A6 UGT1A5	8.21e-04	8	162	2	EFO_0600038
Disease	xerostomia	ANTXR1 WDR72	8.21e-04	8	162	2	EFO_0009869
Disease	triacylglycerol 58:6 measurement	LRP1B TENM2	8.21e-04	8	162	2	EFO_0010440
Disease	interferon-induced protein with tetratricopeptide repeats 3 measurement	STING1 IFIT3	8.21e-04	8	162	2	EFO_0801710
Disease	Primary dilated cardiomyopathy	MYH6 MYH7 SCN5A	8.58e-04	34	162	3	cv:C0007193
Disease	glycine measurement	ANPEP CAPN3 ERMP1 TENM4 GVINP1	9.78e-04	137	162	5	EFO_0009767
Disease	hypothyroidism (biomarker_via_orthology)	MYH6 MYH7 SHH AQP3	1.00e-03	80	162	4	DOID:1459 (biomarker_via_orthology)
Disease	Cardiomyopathy, Hypertrophic, Familial	MYH6 MYH7	1.05e-03	9	162	2	C0949658
Disease	vitamin D deficiency	UGT1A6 UGT1A5 PCNX1	1.10e-03	37	162	3	EFO_0003762
Disease	thyroxine measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A3	1.15e-03	83	162	4	EFO_0005130
Disease	hormone measurement	UGT1A6 UGT1A5 UGT1A4 UGT1A3	1.20e-03	84	162	4	EFO_0004730
Disease	generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology)	SCN5A SCN9A	1.31e-03	10	162	2	DOID:0111294 (implicated_via_orthology)
Disease	Dravet syndrome (implicated_via_orthology)	SCN5A SCN9A	1.31e-03	10	162	2	DOID:0080422 (implicated_via_orthology)
Disease	Muscular dystrophy, limb-girdle, autosomal dominant	MYH6 MYH7	1.31e-03	10	162	2	cv:C5675009
Disease	periodontitis	MYH13 LRP1B TENM2 GVINP1 ANTXR1 PLEC	1.50e-03	223	162	6	EFO_0000649
Disease	Congenital long QT syndrome	KCNH2 SCN5A	1.59e-03	11	162	2	cv:C1141890
Disease	Long QT Syndrome	KCNH2 SCN5A	1.59e-03	11	162	2	C0023976
Disease	Memory Loss	SLC6A3 SLC17A7 SLC17A6	1.71e-03	43	162	3	C0751295
Disease	Age-Related Memory Disorders	SLC6A3 SLC17A7 SLC17A6	1.71e-03	43	162	3	C0751292
Disease	Memory Disorder, Spatial	SLC6A3 SLC17A7 SLC17A6	1.71e-03	43	162	3	C0751294
Disease	Memory Disorder, Semantic	SLC6A3 SLC17A7 SLC17A6	1.71e-03	43	162	3	C0751293

Protein segments in the cluster

Peptide	Gene	Start	Entry
DLTWYQYHSLDVIGF	UGT1A3	481	P35503
HFQVAERALYYWNNE	PPP2R5E	356	Q16537
NIDHLHVGWYQSTYY	EIF3H	111	O15372
CHLAYLFNWLQQYTD	CPN2	401	P22792
VFGNIQQIYEWHRDY	ARHGEF25	206	Q86VW2
QQIYEWHRDYFLQEL	ARHGEF25	211	Q86VW2
LHHWNEIYYFVEQLA	ANTXR1	56	Q9H6X2
HFLYAYGNQIWLSVD	CATSPERB	421	Q9H7T0
GYWVLRLNGEHLYFT	BTNL8	376	Q6UX41
SLYYFQLWDHILENE	ADGRG4	181	Q8IZF6
DVNTHVYYFAHLWDG	GVINP1	1661	Q7Z2Y8
WNFIYVFHTLGQYFQ	GPNMB	171	Q14956
AWPNYYAQAHGLVFV	ARL13A	81	Q5H913
TFAYQNTIYLNLWDH	ANPEP	506	P15144
WLLQHYEAYASALAQ	CELSR2	2136	Q9HCU4
YGYTLQFWHVLAARL	ANO4	871	Q32M45
LNSDINSNHYHQWFY	AGTPBP1	736	Q9UPW5
QTFHSYLEDIINYRW	CECR2	76	Q9BXF3
SLIGQSLSWYNHFYV	ERMP1	476	Q7Z2K6
YLATYVDWHFLLESQ	AOC3	406	Q16853
LFYWYEGLDHALQCV	IL13RA2	171	Q14627
ERALYTWNNGHQVLY	OLFM2	426	O95897
VLFFGSNDYLWTHQA	NSD1	1796	Q96L73
HWGLYIFSLAQLFYT	RFT1	176	Q96AA3
WFHSNDGGNVLYYEV	JAK1	301	P23458
HYAGIVDYNIIGWLQ	MYH7	581	P12883
WEGNLRYAEYSHFVL	ANGPTL7	226	O43827
DGHYSQTYWNLLAIR	ANO7	836	Q6IWH7
AHWTVQQVFYLGHYY	AOC2	251	O75106
RYLYLASNQTNAWGH	AOC2	581	O75106
YGRITLHVFWELNYD	CYFIP1	836	Q7L576
LHVFWELNYDFLPNY	CYFIP1	841	Q7L576
YLWHRFSADLGYNGT	SLC46A1	46	Q96NT5
NLTSNHLLYHYWIAV	FAR1	341	Q8WVX9
IALDFHFNQSLLYWT	LRP1B	1291	Q9NZR2
VFGAYIYWSDRAHAN	LRP1B	2091	Q9NZR2
DYGLFQINSHYWCND	LYZL6	71	O75951
QLIWLYLDHNYISSV	LRRTM4	86	Q86VH4
WSNSLGHLVYVLVYN	GPR176	196	Q14439
SNIGAGYVVHWYQQL	IGLV1-50	46	A0A075B6I6
DAYVNYVFQISVHEW	HERC3	891	Q15034
FQVALGREWYIHTIY	FREM2	3001	Q5SZK8
LGLVYFHYNAFQWAI	KDM6A	136	O15550
RLEEYFQHAWSYTNG	KCNH2	696	Q12809
WYYDPHQATFVNALH	PCNX1	21	Q96RV3
RVYYFNHITNASQWE	PIN1	21	Q13526
YNEAYISFLFVHPEW	KAT14	696	Q9H8E8
ATALAIIYNLWFGYD	GGTLC1	136	Q9BX51
NIRYGLYHSLLEWFH	FUCA1	176	P04066
FNEYLFALQSHLCYW	DDHD2	671	O94830
IWEQIGSSFIQHYYQ	NUTF2	6	P61970
YQSFQVIWRYFHDTL	ENPP1	766	P22413
FINQLCYETALHWYA	LRRC8E	101	Q6NSJ5
HLPYWGQNIINHYFC	OR2D3	181	Q8NGH3
EDAWQSNFLHPVIYY	FOXRED2	521	Q8IWF2
AYYQFGLHCWDLAAA	IMPA2	221	O14732
NWLSEFQLEGYTAHF	CASKIN2	496	Q8WXE0
AQRASWIGYAIAYHL	NAA15	146	Q9BXJ9
AIRVSNYDIFWYTHN	NOX4	181	Q9NPH5
LPFLIHYYASGENWI	OXGR1	86	Q96P68
LWAGAFYLFHVQEVN	SMPD2	366	O60906
FAYYHGLLGNRLWSS	CTSA	221	P10619
DHLYAFFIQWSPEIY	OXR1	601	Q8N573
DFWNYVQHFQALGAY	OTOS	46	Q8NHW6
EAIAGYAQYFHLAAW	FZD5	351	Q13467
YAQYFHLAAWLIPSV	FZD5	356	Q13467
YWLPLYIANVAHFSA	SLC37A2	316	Q8TED4
ANPHNYDAWFDYLRL	CRNKL1	486	Q9BZJ0
LDISYLQYLWEAHTN	FHIP1A	496	Q05DH4
NVYSQWLVGYAASRH	BCL11B	706	Q9C0K0
LYFWYVRTAVDQHLG	PRMT7	491	Q9NVM4
HLANDNFIWIGIYST	FBXO15	106	Q8NCQ5
VEQTDFHYNWLIYHL	DHX36	876	Q9H2U1
SWYHDYGHLELIQLQ	GUSB	506	P08236
LARILAWTYAFYHNG	CYP4F8	31	P98187
AWVYYHLGRLSDAQI	IFIT3	101	O14879
FLYLTFYGHTWQVQD	BBOX1	171	O75936
ILYWFYHEDDTLGNI	FCRL3	506	Q96P31
AEWTSRQHLFYGQYE	IPO9	841	Q96P70
GHYTQLVWANSFYVG	GLIPR1L1	136	Q6UWM5
LVSFQYHNDFIYWLT	CYP4B1	226	P13584
SVYLGLFDINRWYHA	AHCTF1	396	Q8WYP5
RLYDFNSYWRVHAGN	IDS	101	P22304
IENYAGIFHFQFWRY	CAPN3	156	P20807
WLEYYNLERAHGDTQ	SART3	511	Q15020
AAVQDWYHFHYVDIL	SCNN1D	391	P51172
LYVYNNAVFTPEDWH	SACS	156	Q9NZJ4
AIWQALNHYAYRDAV	CDC27	11	P30260
YSWQHTEALLYGFQS	IPO13	461	O94829
YALHLENWLQYFPLS	HS3ST4	336	Q9Y661
NAAFNFVYASHNIWY	TACR2	86	P21452
LNVSEEQHFGLSLYW	IL17RC	296	Q8NAC3
GLYSHYWLLLNVSGF	FADS6	206	Q8N9I5
YAWDNGHQLTYTLHF	OLFML2A	636	Q68BL7
HALLYGLQDLSSGYW	PLEKHM2	51	Q8IWE5
YDLLEDNHSYIQWLF	OGFR	121	Q9NZT2
EHLYNFVIFNNQDYW	RPP40	336	O75818
WHAGRTINDQDFFLY	MAP3K4	271	Q9Y6R4
HANIVAYHGSYLWLQ	MAP4K1	71	Q92918
QWEYGRLNLHYAVVS	QARS1	481	P47897
NTVLYQGHAYPVWDL	TAF5L	376	O75529
GNFNVAHGLAWSYYI	STING1	151	Q86WV6
TYDSWFLVHNFLYQP	SUSD2	641	Q9UGT4
NLSYYHLVPFETDIW	PXDC1	216	Q5TGL8
AGATAGIHWYSQLLY	SHH	426	Q15465
SNIGAGYDVHWYQQL	IGLV1-40	46	P01703
SLGWVLSAYAANVHY	SLC16A14	111	Q7RTX9
FWFDLQAYHQLFYQE	RGS22	696	Q8NE09
VQKHNLSYLFYNWSI	SLC22A16	341	Q86VW1
LFSLGYHQSRWNYRD	GANAB	391	Q14697
GSIVAFNIDFNRWHY	NBEA	2926	Q8NFP9
RWHLQVYAFYEAVAG	GPR150	226	Q8NGU9
FDTQIYTDWANHYLA	NAV2	86	Q8IVL1
IIGYFEHYLQWIEFS	PROM1	746	O43490
ALGLYQWIYHTHEDA	PREX1	781	Q8TCU6
ALRHYYFTNSWNIFD	SCN5A	1581	Q14524
LISLRHYYFTVGWNI	SCN9A	1566	Q15858
INAFYIHWYLHQEGK	TRGV5	46	A0A0B4J1U4
FLYFSNWLHGDLRQY	SELENBP1	321	Q13228
VQYLDVGLWHLAFYN	TENM2	541	Q9NT68
TWRYSYDLNGNLHLL	TENM2	2221	Q9NT68
EEWQYVFLIASLVHY	SLC17A7	466	Q9P2U7
TVNAYVPNARWFDYH	SI	1646	P14410
EWFAHQRHGQGTYLY	RSPH1	116	Q8WYR4
IHYAGTVDYNILGWL	MYH6	581	P13533
RLLYAWDNGHQVTYH	OLFML2B	731	Q68BL8
AVLADIGQHVYQWVY	ABCC12	841	Q96J65
FLSYHIFLTGWDENQ	NOX3	471	Q9HBY0
NWNFLFFPLYYVGHV	SLC35F3	106	Q8IY50
WVNYSAHYSYQVALG	STON2	861	Q8WXE9
VVVHDWLYSYVYQDG	SOAT2	396	O75908
FLFENQTPAHVYYRW	U2SURP	461	O15042
VHYYFDHNSNWNLLI	CCDC134	126	Q9H6E4
ADLFGWSQLIYNHIT	ADD1	156	P35611
YFVEENLQHWSYFQT	ADPRH	211	P54922
AGIVFGLYYDAIWHF	AQP3	116	Q92482
GLYYDAIWHFADNQL	AQP3	121	Q92482
LIIVYWDSAGAAHFY	CHST12	21	Q9NRB3
YLFENGQRVSFFAWH	CLEC11A	251	Q9Y240
LQHGYLVAWLVLDYT	CNGA4	61	Q8IV77
VFPYQTADNIHYWLI	CNGB3	241	Q9NQW8
VGIAVEQLAYYHHDW	CLCN3	541	P51790
QFAWRHFYWYLTNEG	RPS10	61	P46783
HFYWYLTNEGIQYLR	RPS10	66	P46783
WHYLAALSIVAVNYS	TMEM45B	221	Q96B21
WQYVFLIAALVHYGG	SLC17A6	476	Q9P2U8
TWYLTSVYQHNLFFL	XCR1	181	P46094
VEWGYAFDVHLNAFY	UNC50	151	Q53HI1
SWNNHSYLYGLLAFQ	GGCX	156	P38435
AYHALGELPQALAWY	TTC24	126	A2A3L6
VNLDQYVYIHFWALG	TMEM143	191	Q96AN5
YVYIHFWALGQRVGQ	TMEM143	196	Q96AN5
YHVSFETLAEYQRWQ	PHLPP2	226	Q6ZVD8
QFAWRHFYWYLTNEG	RPS10P5	61	Q9NQ39
EYYLNGHWTIEAARA	PAPLN	231	O95428
YVGFFYNVIIAWALH	SLC6A3	151	Q01959
YNVIIAWALHYLFSS	SLC6A3	156	Q01959
SGHATLYWYQQILGQ	TRBV11-2	46	A0A584
LTWYQYHSLDVIGFL	UGT1A1	481	P22309
GWLNLLYYTRGFQHT	TRPV2	506	Q9Y5S1
IWTEDGHSYIYQLLN	WDR72	271	Q3MJ13
DLTWYQYHSLDVIGF	UGT1A5	481	P35504
LVHYAGTVDYNIAGW	MYH13	581	Q9UKX3
IQYLDSGIWHLAFYN	TENM4	531	Q6N022
SGHVSLYWYRQALGQ	TRBV7-6	46	A0A1B0GX31
YWYLTNEGIAHLRQY	PLEC	71	Q15149
SEIWHAYLNNHYQVL	ZMYND12	241	Q9H0C1
AANNVYQYGREWITH	TMEM245	526	Q9H330
SQLAYWLHAFPELYF	TRAM1	171	Q15629
IQPYIHNYSWLLFAA	ZZEF1	1891	O43149
NLTWFQYHSLDVIGF	UGT2B10	481	P36537
VGYFAQVKHLYNWNL	TPTE2	376	Q6XPS3
TEVAEYHYQLGLTYW	TTC37	451	Q6PGP7
TWYQYHSLDVIGFLL	UGT1A6	481	P19224
IWRLYAHVYGNGQSE	TTC27	711	Q6P3X3
FIHSYYNVWLRAQLG	RNF145	491	Q96MT1
SGHNALYWYRQSLGQ	TRBV7-1	46	A0A0A6YYK4
FHASFELWQLQGYSV	UHRF1BP1	141	Q6BDS2
PGVLWIFLDYFQTYH	SLFN5	676	Q08AF3
RIHTRAQWFYEYGNA	ZNF7	601	P17097
DLTWYQYHSLDVIGF	UGT1A4	481	P22310
GFWEQLIHYEFQLFG	DUSP18	146	Q8NEJ0
AGATSLYRWHQNGFY	LGI3	351	Q8N145
LYRWHQNGFYSHQAL	LGI3	356	Q8N145
VWVVLHFALLNAYTY	NALCN	1286	Q8IZF0